Discovery of potent and orally bioavailable degraders of HPK1 based on a novel HPK1 binder

被引：0
|
作者：
Zhang, Zhimin
Wu, Mengqiang
Wang, Ling
Yang, Xi
Zhang, Zhiping
Guo, Liubin
Pan, Hao
Zhao, Mengting
Wang, Linli
Liu, Sirui
Dong, Zhao
Jiang, Chunhua
Zheng, Haowen
Liu, Dongzhou
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4514
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The role of HPK1 in influencing peripheral B-cell tolerance
    Koenigsberger, S.
    Achatz, G.
    ALLERGY, 2008, 63 : 488 - 488
  • [32] Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity
    Banerjee, Monali
    Shrivastava, Ritesh
    Pryde, David
    Middya, Sandip
    Debnath, Sabyasachi
    Middya, Anindita
    Yadav, Dharmendra
    Rawat, Nidhi
    Ghosh, Rajib
    Padaliya, Manisha
    Basu, Sourav
    Surya, Arjun
    CANCER RESEARCH, 2024, 84 (06)
  • [33] Gimme a brake: HPK1 regulates LFA-1 and neutrophil traction
    Simon, Scott I.
    BLOOD, 2013, 121 (20) : 4017 - 4018
  • [34] HPK1 Inhibition Enhancing HFRT Anti -Tumor Immune Response
    Zhang, J.
    Wang, F.
    Shang, S.
    Yan, W.
    Ma, Y.
    Ren, Z.
    Wu, M.
    Ma, J.
    Zhang, Y.
    Yu, J.
    Chen, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S120 - S121
  • [35] First disclosure of a highly potent and selective HPK1 inhibitor that rescues T cell exhaustion
    Mele, Deanna A.
    Grimster, Neil
    Bommakanti, Gayathri
    Shields, Jason
    Morrill, Lucas
    Giblin, Kathryn
    SanMartin, Maryann
    Wang, Yanjun
    Ye, Minwei
    KarapaReddy, Iswarya
    Song, Kun
    Proia, Theresa
    Hariparsad, Niresh
    Richards, Ryan
    Luheshi, Nadia
    Barry, Simon T.
    Fawell, Stephen
    CANCER RESEARCH, 2023, 83 (07)
  • [36] HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway
    Kiefer, F
    Tibbles, LA
    Anafi, M
    Janssen, A
    Zanke, BW
    Lassam, N
    Pawson, T
    Woodgett, JR
    Iscove, NN
    EMBO JOURNAL, 1996, 15 (24): : 7013 - 7025
  • [37] Characterization of Hematopoietic Progenitor Kinase 1 (HPK1) in Multiple Myeloma: a Player in Pathogenesis?
    Bisping, Guido
    Gustavus, Dirk
    Kiefer, Friedemann
    Korsching, Eberhard
    Kienast, Joachim
    Berdel, Wolfgang E.
    BLOOD, 2011, 118 (21) : 1692 - 1692
  • [38] RGT-264 a highly potent, selective and orally bioavailable HPK1 (MAP4K1) inhibitor augments immune activation and anti-tumor immunity
    Xiao, F.
    Liu, H.
    Wu, L.
    Feng, S.
    Liu, Y.
    Xiao, H.
    Li, H.
    Huang, W.
    Ren, X.
    Ren, B.
    Yao, L.
    Lin, J.
    Zhong, W.
    Xie, Z.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S172 - S173
  • [39] Design, Synthesis, and Biological Evaluation of a Series of Spiro Analogues as Novel HPK1 Inhibitors
    Peng, Jingjing
    Ding, Xiaoyu
    Chen, Celia X. J.
    Shih, Pei-Yu
    Meng, Qingyuan
    Ding, Xiao
    Zhang, Man
    Aliper, Alex
    Ren, Feng
    Lu, Hongfu
    Zhavoronkov, Alex
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (11): : 2032 - 2041
  • [40] Design, Synthesis, and Pharmacological Evaluation of Isoindoline Analogues as New HPK1 Inhibitors
    Xie, Chenghu
    Liu, Bo
    Song, Zilan
    Yang, Ye
    Dai, Mengdi
    Gao, Yinglei
    Yao, Yujia
    Ding, Chunyong
    Ai, Jing
    Zhang, Ao
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (23) : 16201 - 16221
12345